Bonti
Latest round
- Series C
Last raised
- Jan 2018
Total raised
- $27M
Investors
- 5
About Bonti
Founded in 2015 and based in California, US, Bonti, Inc. is a biotechnology company that develops neurotoxins for therapeutic and aesthetic use. The company's CEO is Fauad Hasan, and CFO is David Ramsay, who served as CFO of Halozyme Therapeutics, Inc which is a public company. The company's product candidate, EB-001, is an investigational botulinum neurotoxin serotype E (BoNT/E) that is used for post-surgical pain. Though BoNT/E has a similar action mechanism to the marketed BoNT/A products, it has a differentiated clinical profile. The BoNT/E has a fast onset of action (within 24 hours) and a short duration of effect (about 3 to 4 weeks), while the BoNT/A has an onset of action around 3 to 7 days, and duration of effect around 3 to 4 months. BoNT/E can be used in aesthetic and therapeutic uses, including for the treatment of post-surgical and non-surgical musculoskeletal pain.
Who invested in Bonti
5 investors across 2 rounds
See all investors in Bonti
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bonti
Who invested in Bonti?
Bonti has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bonti raised?
Bonti has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bonti last raise money?
Bonti's most recent round on record is a Series C, in Jan 2018.
What does Bonti do?
Founded in 2015 and based in California, US, Bonti, Inc.
Where is Bonti headquartered?
Bonti is headquartered in Newport Beach, US.
Which VCs invest in companies like Bonti?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bonti's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bonti? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.